Krishna Institute Of Medical Sciences Limited · NSE:KIMS
Krishna Institute Of Medical Sciences — Q2 FY26 Earnings Presentation
36 slides from Krishna Institute Of Medical Sciences's earnings presentation, Nov 11, 2025
Slide 1: Corrigendum to Investor Presentation
11th November 2025 The General Manager, The Manager, Department of Corporate Services Listing Department Bombay Stock Exchange Ltd (BSE) National Stock Exchange of India Limited, Phiroze Jheejheebhoy Towers, Exchange Plaza, 5th Floor, Dalal Street, Plot No.C/1, 'G' Block, Mumbai - 400 001. Bandra -
Slide 2: Corrigendum letter (continued)
Please be assured that these updates are purely data corrections and have no impact whatsoever on the Company’s financial statements or performance. The said revised presentation is being uploaded on the website of the Company i.e., https://www.kimshospitals.com/investors/Disclosures under Regulatio
Slide 3: Q2 FY26 Update
Q2 FY26 UPDATE Private & Confidential
Slide 4: Disclaimer
Disclaimer This presentation has been prepared by Krishna Institute of Medical Sciences Limited (the “Company”) solely for informational purposes. It should not be construed as an offer, solicitation, or recommendation to purchase or subscribe for any securities of the Company or its affiliates. The
Slide 5: Driven by a Vision
Driven by a Vision Affordable Quality Care VISION: Best-in-Class Facilities Patient Centric Systems & Processes S To be the most preferred NT healthcare services brand by TIE providing affordable care and best PA clinical outcomes to patients. Clinical Outcome Driven Excellence And to be the best pl
Slide 6: Multi Specialty Care
Multi Specialty Care Brain Eyes Bones and Spine Radiology • Neurology • Ophthalmology • Orthopedics • Imaging • Neurosurgery Gastro Intestinal Tract • Arthroscopic Surgery • Interventional Radiology • Psychiatry • Medical Gastroenterology • Spine Surgery Lab Services • Neuro Rehabilitation • Surgica
Slide 7: Dr. B. Bhaskar Rao - Visionary Behind KIMS
Dr. B. Bhaskar Rao - Visionary Behind KIMS Chairman & Managing Director A legend in CT Surgery, Dr. Bollineni Bhaskar Rao {MBBS, MS, DNB (CT Surgery)} is one of the very few Cardio- Thoracic Surgeons in the country, who performed over 30000 surgeries in his career spanning over more than 25 years. W
Slide 8: Dr. Abhinay Bollineni
Dr. Abhinay Bollineni Chief Executive Officer Dr. Abhinay Bollineni joined KIMS Hospitals in 2013 and spent the next couple of years in Hospital Operations before taking charge of Strategy & Marketing for the Group in 2015. He was appointed as the CEO in 2019. Dr. B. Abhinay completed MBBS from the
Slide 9: Board of Directors
Board of Directors Dr. Bhaskara Rao Bollineni Dr. Abhinay Bollineni Mrs. Anitha Dandamudi Mr. Saumen Chakraborty Chairman & Managing Director Chief Executive Officer Whole-time Director Independent Director, Chairman (Audit Committee) Mr. Adwik Bollineni Mr. Venkata Ramudu Jasthi Mrs. Y. Prameela Ra
Slide 10: Shareholding Pattern - As on 30 September, 2025
Shareholding Pattern - As on 30 September, 2025 th Retail & Others, Retail Pre IPO, 9.7% 6.8% Top Share Holders - DII's & FII's Share Holder No of Shares Share Holding % Category Promoters, 34.1% Promoter 13,64,89,330 34.1% SBI MF 2,38,37,761 6.0% DII Axis MF 2,10,61,205 5.3% DII FII, 16.7% HDFC MF
Slide 11: Modern Medical Technology
Modern Medical Technology 4-Arm HD da Vinci MrGFUS Focussed Tulsa-Pro System Robotic Surgical Ultrasound A non- invasive procedure that System Revolutionary Knifeless Brain uses real-time MRI guidance Facilitates complex surgeries procedure for treating tremors. to precisely deliver thermal that are
Slide 12: Many Firsts...
Many Firsts... • First in Asia in to do Trans catheter • India’s first COVID Double Lung • Number 1 in Nephrology treatments in Tricuspid Valve replacement transplant done in 2020 Andhra Pradesh* procedure done in 2018 • India’s first Breathing Lung transplant • Number 1 in Neurosurgery & Poly • Lar
Slide 13: Key Accomplishments
Key Accomplishments NAL ACCRED TIO IT NA AT ER ION INT QU Y ET LI AF A TY & PAT I E N T S Pharmacie De Qualite (PDQ) American Accreditation Commission Certification Overall PDQ Evaluation ‘Best Patient Friendly Hospital’ NABH Digital Standards Accreditation Ranked No. 1 Hospital International (AACI)
Slide 14: Consistent Performer over 2 decades
Consistent Performer over 2 decades (Rupees in Millions) 30,670 7,590 25,143 6,200 22,235 5,766 .7% : 2 9 26 .9% 16,711 GR G R : CA 5,217 CA 11,287 2,412 4,280 773 1,311 317 263 42 2005 2010 2015 2020 2022 2023 2024 2025 2005 2010 2015 2020 2022** 2023 2024 2025 No. of No. of No. of No. of No. of No
Slide 15: KIMS Journey: From Regional Leader to National Healthcare
KIMS Journey: From Regional Leader to National Healthcare Roadmap Year Andhra Pradesh Telangana Maharashtra Kerala Karnataka 2000 Nellore - 250 2001 Rajahmundry - 195 2004 Secunderabad - 1000 2011 Srikakulam - 300 2014 Kondapur - 220 2017 Ongole - 350 2018 Vizag - 434 2019 Anantapur - 250 Kurnool -
Slide 16: KIMS Journey: Strategic Levers for Future Growth
KIMS Journey: Strategic Levers for Future Growth Consistent Growth Over Two Decades Achieved 27%+ CAGR in Revenue and 30% CAGR in EBITDA, reflecting sustained operational excellence and strategic expansion. Delivering high-quality care through affordable healthcare models, advanced These transplant
Slide 17: Q2 FY26 Updates
Q2 FY26 Updates 15 Private & Confidential
Slide 18: Financial & Operational Highlights - 1/2
Financial & Operational Highlights - 1/2 (Rupees in Millions) FINANCIAL HIGHLIGHTS Q2 FY26 Consolidated • Total Revenue of INR 9,649 Mns, a growth of 23.3% on YoY and 9.8% on QoQ basis. • EBITDA of INR 2,082 Mns, a degrowth of 6.7% on YoY and a growth of 4.3% on QoQ basis. • EBITDA Margin at 21.6% v
Slide 19: Financial & Operational Highlights - 2/2
Financial & Operational Highlights - 2/2 OPERATIONAL Q2 FY 26 Consolidated HIGHLIGHTS • ARPOB grew by 9.8% and a degrew by 2.3% on YoY and QoQ basis respectively. • ARPP grew by 7.3% and a degrew by 1.6% on YoY and QoQ basis respectively. Consoldiated - Q2 FY26 Results Particulars Q2 FY26 Q1 FY26 Q2
Slide 20: Group Operating Performance
Group Operating Performance IP VOLUME (‘000) OP VOLUME (‘000) 12.2% 18.0% 15.3% 22.3% 122 64 1,095 593 57 474 502 56 105 895 H1 FY25 H1 FY26 Q2 FY25 Q1 FY26 Q2 FY26 H1 FY25 H1 FY26 Q2 FY25 Q1 FY26 Q2 FY26 OCCUPANCY* ARPOB (‘000) (2.3%) (6.4%) 2.1% 10.8% 57.4% 60.1% 42.5 43.0 42.0 53.5% 38.4 51.3% 38
Slide 21: Group Operating and Financial Performance
Group Operating and Financial Performance Particulars FY24 FY25 H1 FY25 H1 FY26 Q2 FY25 Q1 FY26 Q2 FY26 Bed Capacity# 3,975 5,179 4,610 6,114 4,610 5,499 6,114 Operational Beds 3,503 4,267 3,813 4,695 3,813 4,387 4,695 Census Beds 2,989 3,689 3,289 3,883 3,289 3,809 3,883 Non Census Beds 514 578 524
Slide 22: Group Financial Performance
Group Financial Performance (Rupees in Millions) TOTAL REVENUE EBITDA 9.8% 25.0% 0.2% 4.3% 18,436 9,649 4,079 2,231 2,082 8,787 1,997 14,753 7,823 4,071 H1 FY25 H1 FY26 Q2 FY25 Q1 FY26 Q2 FY26 H1 FY25 H1 FY26 Q2 FY25 Q1 FY26 Q2 FY26 PBT* PAT* (27.2%) (27.3%) (15.3%) 2,893 1,622 (14.9%) 2,159 1207 1,
Slide 23: Operational and Financial Performance - 1/2
Operational and Financial Performance - 1/2 Telangana Andhra Pradesh Particulars FY24 FY25 H1 FY25 H1 FY26 Q2 FY25 Q1 FY26 Q2 FY26 FY24 FY25 H1 FY25 H1FY26 Q2 FY25 Q1 FY26 Q2 FY26 Bed Capacity 1727 1797 1737 1882 1737 1817 1882 1914 2214 2214 2314 2214 2214 2314 Operational Beds 1612 1682 1622 1694
Slide 24: Operational and Financial Performance - 2/2
Operational and Financial Performance - 2/2 Maharashtra Kerala Karnataka Group Particulars FY24 FY25 H1 FY25 H1FY26 Q2 FY25 Q1 FY26 Q2 FY26 FY25 H1FY26 Q1 FY26 Q2 FY26 H1 FY26 Q2 FY26 FY24 FY25 H1FY25 H1FY26 Q2 FY25 Q1 FY26 Q2 FY26 Bed Capacity 334 659 659 959 659 959 959 509 509 509 509 450 450 397
Slide 25: Ramp-up of Kerala Units
Ramp-up of Kerala Units (Rupees in Millions) Kannur EBITDA Positive Kollam 272.4 152.2 253.6 87.3 28.0 12.4 (35.9) (21.1) Q1FY26 Q2FY26 Q1FY26 Q2FY26 NABH - Entry level NABH - In Pipeline Clinical Talent Expansion: Onboarded senior specialists in high-revenue Emergency & Critical Care Upgrade: Commi
Slide 26: Ramp-up of Maharashtra Units
Ramp-up of Maharashtra Units (Rupees in Millions) Nashik Thane 176.4 298.1 152.5 110.8 55.8 (93.8) (97.9) (64.7) (92.3) (150.0) Q4FY25 Q1FY26 Q2FY26 Q1FY26 Q2FY26 NABH - Entry level NABH - In Pipeline Tertiary Care Expansion: Launch advanced specialties - Paediatric Cardiac Surgery, • 300-bed quater
Slide 27: Ramp-up of AP & Karnataka Units
Ramp-up of AP & Karnataka Units (Rupees in Millions) Bengaluru Vizag QNRI 29.0 238.9 214.0 (253.4) 60.4 Q2FY26 14.4 14.6 (0.3) Q2FY25 Q1FY26 Q2FY26 NABH - Accredited NABH - In Pipeline Advanced Clinical Installations: Commissioned high-end facilities including Strategic capacity expansion targeting
Slide 28: Ramp-up of O&M Units
Ramp-up of O&M Units (Rupees in Millions) Sangli EBITDA Positive Guntur 247.6 230.8 235.3 195.0 14.2 13.5 (22.5) (30.9) Q1FY26 Q2FY26 Q1FY26 Q2FY26 NABH - Entry level NABH - In Pipeline Consultant Model Optimization: Transitioned FFS consultants to full-time • 200-bed facility ramped up to ~50% occu
Slide 29: Speciality Mix
Speciality Mix Others Cardiac Sciences 21% 17% Renal Sciences 9% Mother & Child 10% Group H1 FY26 Organ Oncology Transplant 6% 2% Gastric Sciences 10% Neuro Sciences 11% Orthopaedics 14% 27 Private & Confidential
Slide 30: Payor & Cluster Profile
Payor & Cluster Profile PAYOR MIX CLUSTER TOTAL REVENUE Kerala 4.1% Maharashtra Karnataka 10.6% 0.2% Aarogyasri 5% Andhra Pradesh 25.4% Cash Telangana Corporate 52% Group 13% 59.7% H1 FY26 Group H1 FY26 CLUSTER EBITDA Kerala (0.4%) Maharashtra Karnataka Insurance (3.9%) (6.2%) 30% Andhra Pradesh 28.
Slide 31: Key Achievements in Q2 FY26
Key Achievements in Q2 FY26 29 Private & Confidential
Slide 32: Key Achievements in Q2 FY26
Key Achievements in Q2 FY26 30 Private & Confidential
Slide 33: Expansion plans
Expansion plans Current Incremental Approx. Revised Expected Units New Departments Beds Beds Capex Year of Operation Bangalore (Project-2) - 361 All Specialities 180-200 Cr Q3 FY26 Ongole 350 50 Cancer Centre 40-50 Cr Q3 FY26 Anantapur 250 250 Cancer Centre / Mother & Child 90-110 Cr Q4 FY26 Kondapu
Slide 34: Profit and Loss Statement
Profit and Loss Statement (Rupees in Millions) Consolidated Particulars Q2 FY26 Q1 FY26 Q2 FY25 QoQ(%) YoY(%) H1 FY25 H1 FY26 YoY(%) Operating Revenue 9,607 8,716 7,773 10.2% 23.6% 14,657 18,323 25.0% Other Income 42 71 50 -40.8% -16.0% 96 113 17.7% Total Revenue 9,649 8,787 7,823 9.8% 23.3% 14,753
Slide 35: Corporate Structure (As on 30 September'25)
Corporate Structure (As on 30 September'25) th Krishna Institute of Medical Sciences Limited Units Wholly Owned Subsidiaries KIMS Secunderabad KIMS Nellore KIMS Rajahmundry KIMS Ongole KIMS Hospitals KIMS QNRI KIMS Swastha KHPL (100%) (100%) (100%) (100%) Thane Visakhapatnam Kerala Rajahmundry (100%
Slide 36: Thank You
Thank You 34 Private & Confidential
Krishna Institute of Medical Sciences — Q2 FY26 Earnings Presentation on 6ix